1.3015
price down icon0.38%   -0.0135
 
loading
前日終値:
$1.315
開ける:
$1.3
24時間の取引高:
600.96K
Relative Volume:
0.22
時価総額:
$252.84M
収益:
$314.00K
当期純損益:
$-40.23M
株価収益率:
-4.6482
EPS:
-0.28
ネットキャッシュフロー:
$-84.71M
1週間 パフォーマンス:
-10.88%
1か月 パフォーマンス:
-15.76%
6か月 パフォーマンス:
+12.93%
1年 パフォーマンス:
-47.81%
1日の値動き範囲:
Value
$1.25
$1.35
1週間の範囲:
Value
$1.22
$1.48
52週間の値動き範囲:
Value
$1.03
$2.64

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
名前
Atai Life Sciences N V
Name
セクター
Healthcare (1163)
Name
電話
49 89 2153 9035
Name
住所
WALLSTRASSE 16, BERLIN
Name
職員
54
Name
Twitter
Name
次回の収益日
2024-12-11
Name
最新のSEC提出書
Name
ATAI's Discussions on Twitter

ATAI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ATAI
Atai Life Sciences N V
1.305 252.84M 314.00K -40.23M -84.71M -0.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
486.00 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
592.98 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
570.55 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
248.66 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
243.33 26.46B 3.81B -644.79M -669.77M -6.24

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-18 繰り返されました H.C. Wainwright Buy
2024-04-03 アップグレード Maxim Group Hold → Buy
2022-11-01 開始されました Loop Capital Buy
2021-11-30 開始されました Maxim Group Buy
2021-11-11 開始されました ROTH Capital Buy
2021-10-18 開始されました H.C. Wainwright Buy
2021-09-01 開始されました Jefferies Buy
2021-07-13 開始されました Berenberg Buy
2021-07-13 開始されました Canaccord Genuity Buy
2021-07-13 開始されました Cantor Fitzgerald Buy
2021-07-13 開始されました Citigroup Buy
2021-07-13 開始されました Cowen Outperform
2021-07-13 開始されました Credit Suisse Outperform
2021-07-13 開始されました RBC Capital Mkts Sector Perform
2021-07-08 開始されました Aegis Capital Buy
すべてを表示

Atai Life Sciences N V (ATAI) 最新ニュース

pulisher
05:51 AM

Berenberg starts atai Life Sciences coverage with Positive rating - Investing.com

05:51 AM
pulisher
Mar 31, 2025

How Are Things Looking For ATAI Life Sciences N.V (NASDAQ: ATAI) For The Short Term? - stocksregister.com

Mar 31, 2025
pulisher
Mar 25, 2025

Atai Life Sciences CEO Rao Srinivas sells $101,814 in common shares - Investing.com Australia

Mar 25, 2025
pulisher
Mar 24, 2025

Atai Life Sciences CEO Rao Srinivas sells $101,814 in common shares By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences chief scientific officer sells $17,767 in shares By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Atai life sciences CMO Craig James sells $15,610 in shares By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences chief business officer sells $65,560 in stock By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences chief business officer sells $65,560 in stock - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences chief scientific officer sells $17,767 in shares - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences CFO sells shares worth $45,285 - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Atai life sciences CMO Craig James sells $15,610 in shares - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences director Angermayer buys $2.52 million in shares By Investing.com - Investing.com UK

Mar 24, 2025
pulisher
Mar 24, 2025

Atai Life Sciences director Angermayer buys $2.52 million in shares - Investing.com

Mar 24, 2025
pulisher
Mar 21, 2025

Psychedelic: atai Life Sciences, NRx report quarterly results - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Nasdaq-Listed Biotech Firm Atai Life Sciences to Launch Bitcoin Treasury Strategy - Cryptonews

Mar 21, 2025
pulisher
Mar 20, 2025

ATAI Life Sciences invests $5M in Bitcoin as reserve asset By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 17, 2025

atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights - The Manila Times

Mar 17, 2025
pulisher
Mar 13, 2025

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial - TipRanks

Mar 13, 2025
pulisher
Mar 11, 2025

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression - Yahoo Finance

Mar 11, 2025
pulisher
Mar 04, 2025

Is Atai Life Sciences N.V. (ATAI) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

How is ATAI’s stock performing after recent trades? - US Post News

Mar 03, 2025
pulisher
Mar 01, 2025

Atai Life Sciences N.V. (ATAI): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 28, 2025

12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

ATAI’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Feb 28, 2025
pulisher
Feb 27, 2025

Atai: Following The Path That Spravato Laid And Moving Beyond It - Seeking Alpha

Feb 27, 2025
pulisher
Feb 25, 2025

Comprehensive Market Analysis of Latest Published Different Types of Depression Reports | DelveInsight - GlobeNewswire Inc.

Feb 25, 2025
pulisher
Feb 24, 2025

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference - Yahoo Finance UK

Feb 24, 2025
pulisher
Feb 23, 2025

Biotechs Highlight 6 Stocks Insiders Are Buying Now - 24/7 Wall St.

Feb 23, 2025
pulisher
Feb 20, 2025

Atai Life Sciences Raises $63.3 Million After Closing Public Offering -February 20, 2025 at 10:10 am EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

atai Life Sciences completes public offering, raising $63.25M - Proactive Investors UK

Feb 20, 2025
pulisher
Feb 20, 2025

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - Yahoo Finance UK

Feb 20, 2025
pulisher
Feb 19, 2025

Apeiron Investment Group purchases $22.8m in ATAI Life Sciences shares By Investing.com - Investing.com Australia

Feb 19, 2025
pulisher
Feb 19, 2025

Drug developers struggle in 2024; Fibrogen, Acadia, Atai post gains - BioWorld Online

Feb 19, 2025
pulisher
Feb 13, 2025

atai Life Sciences announces pricing of $55M public offering of shares - Proactive Investors UK

Feb 13, 2025
pulisher
Feb 13, 2025

Trade Desk Posts Downbeat Revenue, Joins Aspen Aerogels, Fastly And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Feb 13, 2025
pulisher
Feb 13, 2025

Atai Life Sciences Prices $55 Million Stock Offering -February 13, 2025 at 04:47 am EST - Marketscreener.com

Feb 13, 2025
pulisher
Feb 12, 2025

ATAI Life Sciences Secures Massive $55M War Chest for Breakthrough Mental Health Treatments - StockTitan

Feb 12, 2025
pulisher
Feb 12, 2025

atai Life Sciences Announces Pricing of Public Offering of Common Shares - Yahoo Finance

Feb 12, 2025
pulisher
Feb 12, 2025

atai Life Sciences unveils $55M public offering to advance mental health treatments - Proactive Investors USA

Feb 12, 2025
pulisher
Feb 12, 2025

atai Life Sciences Secures Major Funding: $55M Share Offering to Revolutionize Mental Health Treatment Pipeline - StockTitan

Feb 12, 2025
pulisher
Feb 11, 2025

Atai CEO Rao optimistic about psychedelic therapies despite Lykos setback (ATAI:NASDAQ) - Seeking Alpha

Feb 11, 2025
pulisher
Feb 10, 2025

Evaluating ATAI’s financial ratios for a profitable investment - US Post News

Feb 10, 2025
pulisher
Feb 10, 2025

Get in on ATAI Life Sciences N.V’s (ATAI) buy-in window today! - SETE News

Feb 10, 2025
pulisher
Feb 08, 2025

atai Life Sciences CEO discusses success of BPL-003 alcohol use disorder trialICYMI - Proactive Investors USA

Feb 08, 2025
pulisher
Feb 07, 2025

ATAI Life Sciences N.V (NASDAQ: ATAI) Has Succeeded In Attracting Investors This Year, The Stock Is Up 59.40% Year-To-Date – Marketing Sentinel - Marketing Sentinel

Feb 07, 2025
pulisher
Feb 06, 2025

atai Life Sciences-backed psychedelic drug could offer superior value, analysts believe - Proactive Investors USA

Feb 06, 2025

Atai Life Sciences N V (ATAI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
大文字化:     |  ボリューム (24 時間):